Michael P Cooke Net Worth & Insider Trades

Michael P Cooke - Chief Scientific Officer, Magenta Therapeutics, Inc

As of December 2, 2019

What is Michael P Cooke's Net Worth?

The current estimated net worth of Magenta Therapeutics, Inc's Chief Scientific Officer, Michael P Cooke, is estimated to be about $768.32K . Michael P Cooke owns about 240,523 units of Magenta Therapeutics, Inc common stock. In the last year at Magenta Therapeutics, Inc, Michael P Cooke has sold an estimated value of $654.33K worth.

What is Michael P Cooke's Past Insider Trading?

Michael P Cooke's largest sale order was 7,500 units , worth over $107.98K on July 2, 2019. In total, Michael P Cooke has made about 12 transactions over a year of their time at Magenta Therapeutics, Inc. Michael P Cooke usually trades in September, with the busiest year in 2019. The most recent transaction was a sale order of 7,500 units , worth over $97.52K on December 2, 2019.

Michael P Cooke

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Michael P Cooke's' Mailing Address?

  • Mailing address is C/o Magenta Therapeutics 50 Hampshire Street Cambridge MA 02139 MA

Magenta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jason Gardner, D.Phil. 2020 $530,000 - $2,309,592 $262,000 $1,256 $3,102,848
Jason Gardner, D.Phil. 2019 $515,000 - $903,764 $231,750 $487 $1,651,001
John C. Davis, Jr., M.D. 2020 $445,376 - $1,153,528 $162,000 $1,256 $1,762,160
John C. Davis, Jr., M.D. 2019 $417,000 - $345,899 $150,120 $502 $913,521
Stephen F. Mahoney 2020 $70,000 - $1,888,655 - $475 $1,959,130
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm

What are Magenta Therapeutics, Inc's Past Insider Trades?

Magenta Therapeutics, Inc's most recent insider trade came on September 20, 2021 by Kristen Stants who sold 5,736 units worth $38.6K . In the last 3 years, insiders at Magenta Therapeutics, Inc have sold an estimated value of $4.21M and bought an estimated value of $10.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jason Gardner, See Remarks,  Michael P Cooke, Chief Scientific Officer,  and Kristen Stants, Chief People Officer .

Magenta Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1